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ABSTRACT
Objectives: This study involved the development of a
question prompt list (QPL) booklet designed to facilitate
communication and shared decision-making between
parents/carers of children diagnosed with attention-deficit/
hyperactivity disorder (ADHD) and their clinicians; and
user-testing of the QPL to assess its usability.
Design: Best practice in information writing and design
was used to format the QPL content into a 16-page
booklet. We then applied user-testing, which uses mixed
methods to assess document performance with small
cohorts of participants and then improves it in an iterative
process. Individual interviews assessed the ability of QPL
users to locate and understand key points of information,
followed by a semistructured questionnaire, to ascertain
their general views about the booklet.
Setting and participants: Testing was undertaken with
two cohorts of 10 parents/carers of children with ADHD
(n=20); matched on age, gender and educational
attainment.
Tested documents: In round 1, we tested 15 key points
of information related to the QPL. Participant responses
and feedback from round 1 informed a revised version of
the booklet, tested in a subsequent round.
Primary outcome measure: The target was for 8/10 of
the participants to be able to find and demonstrate an
understanding of all key information points, in accordance
with European guidelines for medicine leaflet testing.
Results: After round 1, problems related to 4/15
information points were identified (booklet purpose;
preparing for appointments; asking about a second
medical opinion; selecting which questions to ask).
Participants also made suggestions regarding the
booklet’s layout and design. After round 2, all information
points were located and understood by at least 8/10
participants.
Conclusions: This is the first study to have developed a
usable ADHD-specific QPL for use by parents/carers of
children with ADHD during clinical consultations, and the
first demonstration of the utility of user-testing methods
in ensuring QPL usability.
INTRODUCTION
Attention-deﬁcit/hyperactivity disorder (ADHD)
is a chronic and impairing neurodevelopmental
disorder of childhood.1 It is characterised
by symptoms of inattention, hyperactivity and
impulsivity.2 3 The target of ﬁrst-line treatment
with stimulant agents (eg, methylphenidate) is
to enhance the action of norepinephrine and
dopamine, thereby alleviating ADHD symp-
toms.4–6 Despite an understanding of the neuro-
biological origins of ADHD and the
demonstrated efﬁcacy of these medicines, there
remains a signiﬁcant amount of controversy sur-
rounding ADHD and a strong sense of unease
within the public sphere about using stimulant
medicines as ﬁrst-line therapy.7–9
These polemic discussions have only been
strengthened by the recognition that the
prevalence of ADHD continues to rise,10 a
fact that many advocate is the result of lax
diagnostic and prescribing practices, and
widening of the diagnostic criteria used to
deﬁne the disorder.11–14
Therefore, although the use of pharmaco-
therapy is regarded as standard clinical prac-
tice for the management of ADHD symptoms
throughout international treatment guide-
lines, parents and carers (henceforth referred
to as parents for ease of reference) of children
who have received an ADHD diagnosis often
have difﬁculty making decisions about treat-
ment.15 16 Parents have expressed frustration
and confusion with sources of ADHD-related
information and a desire to access relevant,
Strengths and limitations of this study
▪ This is the first study to have developed a tailored
resource intended to facilitate communication and
shared decision-making between parents/carers
of children with attention-deficit/hyperactivity dis-
order and their clinicians.
▪ The study represents the first demonstration of
the utility of user-testing as a method in asses-
sing the performance of this type of resource.
▪ The user-testing method does not test the docu-
ments’ influence on treatment decision-making or
long-term outcomes such as adherence to
therapy, which require assessment in future work.
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reliable resources to assist in their treatment
decision-making.17
Non-adherence to prescribed treatments for ADHD
may be as high as 87% in some instances,18 and has been
associated with poorer outcomes for the child and overall
increased healthcare burden.19–21 While this may be
attributed to a number of factors, lack of adequate infor-
mation provision about the disorder and its treatments
appears to repeatedly underscore poor adherence.18 22 23
Information from healthcare professionals and shared
decision-making
Healthcare professionals (HCPs) are an important
source of reliable information for parents.17 24 However,
some parents have reported difﬁculties communicating
with HCPs during clinical consultations, raising concerns
such as: general difﬁculty obtaining information, receiv-
ing insufﬁcient information, and receiving excessive
information that is irrelevant to their speciﬁc concerns
and difﬁcult to absorb during the limited consultation
time.17 25 26 These communication difﬁculties can lead
to an inability to express treatment preferences and
poor adherence to prescribed regimens.26
This is why the practice of shared decision-making
(SDM), a collaborative approach used between clinicians
and patients to arrive at agreed treatment decisions, has
become a focus of great interest in the literature.27 28
Recognised by many as the gold-standard in the delivery of
healthcare services,29 SDM requires clinicians to engage
with their patients during clinical consultations, facilitating
an exchange of information and values to assist in reach-
ing a point of shared agreement about treatment.29 This
process decreases the asymmetry of information and
authority that can often be present during clinical consul-
tations and empowers patients to take control over their
treatment decisions.28 In the paediatric care setting, involv-
ing parents in treatment decision-making has been
demonstrated to improve treatment adherence and overall
health outcomes for the child.30
With regard to ADHD and its management, the import-
ance of SDM has been emphasised throughout inter-
national treatment guidelines.31–33 However, greater
efforts are required to facilitate SDM during clinical con-
sultations.34 Tools such as question prompt lists (QPLs),
which assist patients in asking questions during clinical
consultations, may prove to be a useful approach in
addressing this.
QPL for ADHD
QPLs contain structured lists of disease and treatment-
speciﬁc questions intended for use by patients as a
prompt for question-asking during clinical consultations.
QPLs are designed to facilitate communication between
patients and their clinicians and, in turn, encourage
SDM. They have been demonstrated to be effective facili-
tators for communication during clinical consultations
in oncology and palliative care settings.35 36
Development of a QPL for ADHD may help address a
number of issues, such as: (1) concerns raised by
parents of children with ADHD about the availability of
relevant and reliable information sources; (2) difﬁculties
experienced communicating with HCPs during clinical
consultations and (3) need for greater efforts to
promote SDM. Such a QPL would have the additional
beneﬁt of addressing parents’ desire to use written
resources as a prompt for communication with a HCP
and the inability of some parents to ask the right ques-
tions during consultations.17 25 26
In light of this, we developed and validated the
content of an ADHD-speciﬁc QPL. The questions were
derived through a systematic analysis of existing ADHD
and QPL-related resources, and validated by clinicians,
researchers, parents and consumer advocates in a
three-round web-based Delphi study (submitted for pub-
lication). The QPL consists of 88 questions addressing a
range of ADHD-related issues including: (1) diagnosis;
(2) understanding ADHD; (3) treatment: (i) medicines,
(ii) psychological and alternative; (4) healthcare team;
(5) monitoring ADHD; (6) managing ADHD; (7) future
expectations: (i) approaching adolescence, (ii) health
and medicines, (iii) academic progress, (iv) social pro-
gress; and (8) support and information.
The QPL does not include any information about
ADHD or ADHD-related issues, rather, it consists of a
list of questions pertaining to the above eight topic
areas, which parents can choose to ask their child’s
clinicians. By encouraging question-asking during clin-
ical consultations, it is anticipated that the QPL will
help increase parents’ knowledge about ADHD and its
treatments and consequently enhance the potential for
SDM between parents and clinicians about treatment
options.
Prior to assessing these outcomes, it is essential to ﬁrst
ensure that the QPL is presented in a user-friendly format
and that its content is easy to understand. User-testing was
deemed to be a suitable and thorough approach to evalu-
ating these aspects of the QPL. This study aimed to: (1)
format the 88 questions derived from our previous work
into a booklet using principles of good information
writing and design and (2) test the performance of this
booklet using established user-testing methods. To the best
of our knowledge, this is the ﬁrst application of user-testing
methods to evaluating any QPL.
In utilising this approach we asked two research ques-
tions, ﬁrst, whether parents of children with ADHD
could locate and understand key questions and pieces of
information in the QPL and second, if the iterative appli-
cation of user-testing could inform the development of a
revised and improved version of the QPL.
METHODS
There were two key phases involved in this study: (1) for-
matting the QPL into a booklet; and (2) applying user-
testing methods to evaluate its performance.
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Formatting QPL into booklet form
The 88 questions formed the main text of the QPL and
were incorporated into a booklet format using a similar
approach to that adopted by Langbecker et al.37 The
booklet lists the questions according to their respective
topics and includes instructions for parents, outlining
who the booklet is for and how it should be used.
The instructions emphasise that the booklet may not
provide exhaustive coverage of the questions parents
may wish to ask and encourage them to add their own
questions. Parents are also advised against asking all the
questions during one consultation and asked, rather, to
identify those questions that are relevant to their child’s
needs at that speciﬁc point in time.
Key writing and design principles for producing
easy-to-understand healthcare materials38 were followed
and included use of a large, clear font; inclusion of white
space around the text; use of subheadings, bulleted
points and bold text to highlight information; inclusion
of culturally diverse images achieved by applying an artis-
tic cross-hatch effect over the images so faces were not
readily identiﬁable; and inclusion of a cover designed to
be attractive to parents. A colour-coded contents page
was included to further enhance the usability of the
booklet. A blank, lined page was provided at the end of
each topic for inclusion of additional questions or notes.
The ﬁrst draft of the QPL was a 16-page, slightly smaller
than A5 sized, wire spiral-bound booklet titled “Asking
Questions about ADHD: Questions to ask your child’s
healthcare provider about ADHD and its treatment.”
User-testing
User-testing is an established method that involves the
performance-based evaluation of written patient materi-
als, speciﬁcally, their ease of use and clarity.39 40 It has
been primarily used to evaluate medicine information
leaﬂets developed by pharmaceutical manufacturers,
medicine information booklets and participant informa-
tion sheets for clinical trials,41–43 but has also been
applied to decision aids44 and medicine label wording.45
Unlike readability formulae, which rely purely on word
and sentence length,46 47 user-testing assesses how a
document performs with its intended users.
The process involves individual interviews with cohorts of
10 participants, where they are provided with a copy of the
document, and presented with a series of approximately 15
questions to determine their ability to locate and under-
stand key points of information within it.39 40 48 The ques-
tionnaire is followed by a brief semistructured interview to
ascertain participants’ views about the format, design and
layout of the document.48 After the ﬁrst round of inter-
views is completed, the document is revised to address any
problems identiﬁed from participant feedback, using good
practise in writing and information design.49 The revised
document is tested with a second cohort and this iterative
process continues until all issues with the document are
resolved. According to the standards set by the European
Union (EU), this is indicated by 8 of the 10 users being
able to ﬁnd and understand responses to all questions in
the structured questionnaire.49
Participants
Twenty parents of children (aged between 3 and
18 years) with a clinical diagnosis of ADHD (the intended
users of the QPL) were recruited by a market research
company or through an Australian ADHD support group
Facebook page.
In each cohort of 10 participants, there were no more
than 3 participants who had completed tertiary educa-
tion and at least 1 belonged to the following age categor-
ies 30–39, 40–49 and 50–59 years. Similar participant
proﬁles in terms of likely inﬂuences on testing (gender,
age and educational level) were maintained in the two
rounds of testing. To increase the rigour of the testing
process, participants could not take part if they regularly
used written information documents as part of their
occupation or if they were HCPs.
Tested materials
The materials tested were: (1) the ﬁrst draft of our
ADHD-speciﬁc QPL, comprising 16 pages and (2) a
revised version of the QPL, with changes made to the
wording, layout and format based on the responses to
the user-testing questionnaire and parent feedback from
round 1, and by applying good practice in information
writing and design.
Outcomes
The main outcome measure was participants’ ability to
locate and demonstrate an understanding of 15 key
points of information and questions in the QPL
(table 1). These key items were selected by RA to test
the usability and clarity of the information in the QPL,
and checked for relevance by PA and DKR, after which
some modiﬁcations were made. Any further differences
were discussed between RA and PA until consensus
about the questions was achieved. The questions were
categorised into three themes (facts, actions and expla-
nations) and each was presented to the participants in
an order different to that of the natural order of the
information in the QPL. Participant responses were used
to score whether the information was found (‘yes’ or
‘no’) and, if found, whether it was understood (‘yes’ or
‘no’). The time taken to read the booklet and to com-
plete the questionnaire was also measured. The inter-
viewer also made ﬁeld notes to document how the
booklet was being used and listed any comments made
by the participants during the testing process.
Procedure
Round 1: testing the original QPL booklet
Participants were given a copy of the booklet and
instructed to read it at their own pace, without the inter-
viewer present. After reading the booklet, they were
asked to use it to locate the answer to each of the 15
structured questions and to explain what they had
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Table 1 User-testing questions relating to the 15 key information points in the QPL and participant responses
Questions
Round 1 (n=10)
Number of participants
Round 2 (n=10)
Number of participants
Able to
find
information
Able to
understand
information
Able to find
information
Able to
understand
information
Facts
Q1. What is the main purpose of this booklet? 8 8 10 10
Q4. Who is this booklet written for? 10 10 10 10
Q7. Who has been involved in the writing of this booklet? 10 10 10 10
Q9. How many topics does this booklet cover? 10 10 10 10
Actions
Q3. Imagine that you have been given this booklet before an appointment with your child’s doctor.
What does the booklet suggest you should do in preparation?
6 6 10 10
Q5. Imagine that you are concerned about how ADHD may affect your child as he/she grows older.
What question would you ask your child’s doctor to best reflect this concern?
10 10 10 10
Q8. Imagine that you are now in the consultation with your child’s doctor and the doctor mentions that
another healthcare professional may need to be involved with your child’s care.
What section would you refer to for questions about this topic?
9 9 10 10
Q10. Imagine that your child’s doctor has recommended some form of treatment for your child but you are
not yet ready to make a decision about whether or not to start this treatment.
What question could you ask your child’s doctor to best reflect this concern?
7 7 8 8
Q12. Imagine that you, personally, are not coping well with your child’s ADHD.
What question could you ask your child’s doctor to best reflect this concern?
10 10 9 9
Q14. Imagine that you are concerned about the medicines used to treat ADHD.
What section would you refer to for questions about this topic?
10 10 10 10
Q15. Imagine that you would like to know about the causes of ADHD.
What question could you ask your child’s doctor to best reflect this?
10 10 10 10
Explanations
Q2. The contents page contains different coloured tabs along the right border.
What do these different colours indicate to you?
10 10 10 10
Q6. This booklet contains many questions about a range of topics.
What does the booklet say about choosing which questions to ask your child’s doctor during a consultation?
6 6 8 8
Q11. What does the booklet say about how you should use the spaces provided after each topic? 10 10 10 10
Q13. In your opinion, a user of this booklet turning to page 20 (47 in round 2) would be in search of
questions relating to what?
10 10 10 10
ADHD, attention-deficit/hyperactivity disorder; QPL, question prompt list.
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understood, where applicable. Participants were next
asked a few open-ended questions about the QPL
booklet, namely, their general impressions, appearance
and booklet size, font style and size, images and graph-
ics, and organisation of information, to gather qualita-
tive data about the booklet. All semi-structured
interviews were audio recorded and transcribed verbatim
with participant permission. Thematic analysis50 was
used to identify the key themes in the qualitative data.
Round 2: rewording, redesign and reassessment
of the QPL booklet
Following round 1, the QPL booklet was edited based
on participant responses. Changes made were either
content or aesthetics-based. Content changes were those
that were anticipated to assist participants in locating
and understanding items in the structured question-
naire, while aesthetic changes were those related to par-
ticipant feedback during the semistructured interview.
The revised QPL booklet was tested using the same pro-
cedure outlined previously.
RESULTS
Testing of original QPL booklet (round 1)
Quantitative data
The original QPL booklet was tested by 10 parents of
children diagnosed with ADHD. Of these, seven were
women and three were men, aged between 33 and
50 years. Only three had obtained a tertiary level of
education.
Participants took an average of 8 min (range 6–12) to
read the booklet. The structured questionnaire was com-
pleted in an average of 22 min (range 8–48). Table 1
outlines the number of participants who were able to
locate and understand the questionnaire items in each
round of testing. On the basis of these results, partici-
pants could not locate the appropriate section in the
booklet (rather than not being able to understand the
information) for the following 4 (of the 15) points
(table 1):
A. The main purpose of the booklet (Question 1);
B. Using the booklet to prepare for an upcoming
appointment (Question 3);
C. Selecting which questions to ask the clinician
(Question 6);
D. Asking about obtaining a second medical opinion
(Question 10).
Qualitative data
The thematic analysis of the semistructured interviews
identiﬁed four themes: (1) concept of a QPL booklet,
(2) appearance and graphics, (3) content and language
and (4) organisation of information and user-
friendliness. Similarities and differences in the partici-
pants’ views regarding these themes were noted and illu-
strated by verbatim quotes from the participants.
Concept of a QPL booklet
The QPL booklet was extremely well-received by partici-
pants in round 1, with all indicating that they would use
this resource if made available to them: “I actually have got
more information from here [QPL] than what I’ve had in
years…The key about learning about this disease is to con-
stantly ask questions.” [P6]; “It’s fantastic, it’s the best
[resource] I’ve seen for ADHD…this is brilliant” [P2].
They felt that the QPL would address some of the difﬁ-
culties they experienced during clinical consultations:
“Most parents are still in this grey area [regarding] what to
ask and do feel frazzled when they go to the doctors” [P1].
The parents also provided insight into their views on
the potential applications and beneﬁts of the resource:
“I didn’t really think…how is that [puberty] going to
affect him [son] until I read this booklet” [P1]; “When
you get a bombardment of information, you don’t always
remember. So it gives you the chance to write down the
answers that the health care professional has given
you…” [P2].
The QPL was viewed by some parents as a resource they
could share with their friends and children: “I’d actually
encourage him [son] to read this because it may help
him understand a bit more…what the condition is” [P3].
The only reservation parents had about the QPL was
the anticipated need for increased HCP awareness and
education about the resource.
Appearance and graphics
All participants agreed that the booklet itself was an
appropriate size: “Small enough…to put in a work bag
or handbag” [P3] as well as the font size of the content.
There was a general sentiment that the QPL was ‘very
well put together’ [P2], of ‘brilliant quality’ [P2], “The
colours are nice and vibrant so it grabs your attention”
[P3] and the colours used created a ‘positive vibe’ [P6].
One parent, however, made the remark that “You might
want to think of having a more durable cover” [P4].
There were mixed views regarding the images, specif-
ically the artistic cross-hatch effect to blur and
de-identify the subjects. The majority responded posi-
tively to these images and provided interesting com-
ments about the merit of the approach used, aside from
imparting anonymity to the subjects: “It’s very hard to
represent the full diversity of cultures and backgrounds
in photos. So I think it’s clever…otherwise it could be
misinterpreted as being exclusive” [P4]; “That…effect
on the photo reﬂects what you feel about your child…
and maybe what your child is feeling like as well” [P9].
Three participants expressed a preference for ‘normal’
[P10] clear images primarily noting the sentiment: “It’s
more personalized when you can see the faces” [P3].
However, as the majority preferred the effect used, this was
maintained in the revised version of the QPL.
Content and language
Overall, the parents expressed that the content of the
QPL was appropriate, and afﬁrmed the relevance of the
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included instructions and questions. “You’ve divided it
into easy to digest paragraphs which makes it easier to
read” [P7].
The different topics in the booklet were described as
being ‘really clearly deﬁned’ [P4] and “It’s good that it’s
[the questions] all in point [bullet] form” [P6]. All
agreed that the language used throughout the QPL was
easy to understand: “It’s clearly and plainly written
which I think will help a variety of people with a variety
of literacy levels” [P4].
Requests to improve the content of the QPL related to
the inclusion of:
▸ Information about disorders related to ADHD;
▸ A list of the various medications available for ADHD
and their effects;
▸ A list of the types of HCPs that should be involved in
ADHD management;
▸ Information about ‘common misconceptions’ [P10]
surrounding ADHD;
▸ Contact details for ADHD support groups and websites.
Some parents also requested the inclusion of positive
afﬁrmations and parenting tips, and a section about the
long-term outcomes of children with ADHD.
The authors chose not to include these items in the
revised version of the QPL as they were viewed to poten-
tially alter the purpose of the booklet from one which
encourages parents to ask questions and obtain tailored
responses to one which provides general information
that may be misinterpreted by parents or irrelevant to
their particular needs. The questions included in mul-
tiple sections of the QPL provide opportunities for
parents to discuss these topics with their clinicians and
to obtain the best advice for their child’s particular
situation.
However, we included a question on the impact of diet
on ADHD in the revised version.
Order of information and user-friendliness
The order of the information in the booklet was felt to be
appropriate by all participants. Positive comments were
also provided about the user-friendliness of the booklet,
particularly the colour-coding, paper quality and the use
of ring-binding to hold the booklet together.
Parents suggested four key improvements to enhance
the booklet’s usability: (1) inclusion of a cover page for
each topic; (2) inclusion of tabbed topic dividers; (3)
addition of greater writing space and (4) change in the
paper type to one with a more matte ﬁnish, “Not every
pen would work on this paper” [P7].
Revisions of original booklet
Revisions were made to the booklet to address the four
key points of information parents had difﬁculty locating
as well as the suggestions provided in the qualitative
data. The revised booklet was A5 in size (slightly larger
than the original version) and 50 pages in length (vs 16
in the original)—selected pages of the original and
revised versions of the booklet are presented in ﬁgures 1
and 2.
Revisions of QPL content
The overall structure of the booklet remained largely
unchanged, however, some adjustments were made to
the headings in the introductory section to address the
trouble experienced by parents in locating information
points in the ﬁrst round of user-testing (speciﬁcally,
points A, B and C, above). These changes are outlined
in box 1.
Aesthetic modifications
Aesthetic changes were made to enhance the user-friend-
liness of the booklet, help better differentiate the sec-
tions, and allow parents to navigate the booklet with
greater ease (and to locate the response to point D
above, (asking about obtaining a second medical opinion
(Question 10))). These changes are outlined in box 2.
Testing of revised information (round 2)
Quantitative data
The revised booklet was tested by a further 10 parents: 6
women and 4 men, aged between 31 and 53 years, with
only 3 having obtained a tertiary level of education.
Participants took an average of 7 min (range 3–14,
median 5.5 min) to read the booklet, which was similar
to round 1. The structured questionnaire was completed
in an average of 21 min (range 15–30, median 20 min),
again, similar to round 1. These results suggest that
despite the increase in the overall thickness of the
booklet during the second round, parents were able to
navigate the booklet within the same timeframe.
Table 1 shows that responses to all 15 of the structured
user-testing questions were located and understood by at
least 8 of the 10 participants. As this is the target set by
the EU in medicine leaﬂet testing,49 we concluded the
user-testing process at this stage (although further small
changes were made based on participant feedback).
Qualitative data
Concept of a QPL booklet
As in round 1, all parents expressed that they would use
the booklet. Again, the QPL was met with very positive
responses from participants who reiterated the import-
ance of such tailored information resources being made
available to them: “Sometimes you walk into the doctor’s
surgery, you’re overwhelmed, you forget [things to ask],
you walk out thinking…I didn’t ask what I was supposed
to” [P15]. “I would call it [the QPL] a conﬁdence book…
A question book is better [than a book of information]
because it makes the parent think about things rather
than being told how to do it, it allows the parent to use
their own interpretations and their own initiative” [P13].
The relevance of the QPL and its potential applica-
tions and beneﬁts were also addressed by the parents:
“There’s a lot of questions in here that…I wouldn’t have
thought of…so it gives you that extra edge” [P12]. The
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QPL was seen as a resource that could also prove useful
to family and friends: “If the parents and the child sit
down and read it together…when they go to see the
doctor, the child can ask the doctor some questions”
[P13].
Appearance and graphics
The size of the QPL was viewed to be appropriate by all
except two participants, who felt the QPL could be
slightly smaller. However, all agreed that the font size
used was appropriate.
The colour scheme used and the booklet’s aesthetic
appearance received equally positive praise: “I love it
because…it’s not identiﬁable as [a resource for] ADHD.
It looks like a diary, you know I want it to be discrete,
and you’ve done that” [P15].
The images used and the artistic effect previously
described were well received by all except two: “I like the
vaguery of the imagery. It’s implying that the condition
is still a bit unknown but it’s not beyond help” [P13];
“It’s the recognition that this could be anybody’s child,
boy or girl, all ages—it’s wonderful” [P11].
Content and language
The appropriateness and relevance of the QPL content
in addition to the newly added ‘This booklet belongs to’
page and the ‘My Contacts’ section was conﬁrmed by all
participants: “I like how I can put his [son’s] name here,
it becomes personal…I love this part [‘My Contacts’], I
would be writing all of my contacts here” [P15].
The language used throughout the QPL was, again,
viewed to be straightforward and easy to understand. For
the same reasons outlined following round 1, we
decided not to include substantive information about
ADHD, despite some requests for this, as the purpose of
the booklet is to encourage question asking rather than
providing general information that may not be appropri-
ate or relevant to all users.
Order of information and user-friendliness
The results from the interviews revealed that all of the
parents were happy with the order of the information,
with one stating: “I like that you’ve gone through the
process…really, from the beginning through to the
future expectations as they [children] have gone through
the years” [P11].
All parents agreed the space provided for the addition
of notes or further questions was excellent. The ring
binding was described as being ‘sturdy and strong’ [P11]
and enhanced the functionality of the booklet.
Despite the increase in the thickness of the booklet
compared with its initial tested format, the parents
Figure 1 Introductory page from the original version of the question prompt list (on left) and revised version (on right) following
first round of testing. Key change displayed here is the addition of subheadings to break up the text and to aid navigation. ADHD,
attention-deficit/hyperactivity disorder.
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found the revised version to have great user-friendliness
and the inclusion of the tabbed section dividers was par-
ticularly well-received.
However, there was a request for greater contrast in
the colours used to distinguish the different sections/
topics. As this was only an aesthetic change to the
revised version of the booklet and given that the EU
targets for document testing were achieved in round 2,
the authors deemed that a subsequent round of testing
would not be required.
DISCUSSION
Guidelines for producing written health materials and
principles of good information design were adopted to
inform the rigorous development of an ADHD-speciﬁc
QPL (in booklet form) intended for use by parents and
carers of children with ADHD. The QPL is intended to
empower parents to ask questions during clinical consul-
tations, thereby increasing their knowledge about
ADHD and its treatments and enhancing the potential
for SDM with clinicians. For the ﬁrst time, user-testing
methods were applied to evaluate the performance of
the QPL with its intended users. In doing so, we were
able to conﬁrm: (1) that parents were able to locate and
understand key questions as well as pieces of information
within the booklet and (2) that the iterative process of
user-testing led to the identiﬁcation of weaknesses in the
document and, consequently, to the development of an
improved version of the QPL addressing these issues.
To the best of our knowledge, this is the ﬁrst demon-
stration of the utility of user-testing methods in assessing
the performance and usability of any QPL. In a previous
study involving development of a QPL for palliative care,
the authors noted that a number of HCPs and an expert
in consumer materials reviewed the QPL prior to its pre-
liminary testing in a clinical environment.36 Although
little detail was provided, the review process did not
involve feedback from the intended users of the QPL
and also appeared to be more focused on the relevance
and appropriateness of the QPL content, rather than
usability of the QPL. This was also the case in the study
by Langbecker et al,37 which involved development of a
QPL for patients with primary brain tumours. Their
approach involved an iterative review process whereby
the QPL was mailed to intended users and a telephone
interview conducted a week later to ascertain areas of
improvement. Based on the ﬁndings of the current
study, we propose that user-testing may provide a more
structured approach to not only ensuring the relevance
Figure 2 New sections added to the revised version of the question prompt list following the first round of testing. The page on
the left provides room for parents to personalise the booklet by including their child’s name and a contact number. The page on
the right is the ‘My Contacts’ section, which provides space for parents to include the contact details of the healthcare
professionals involved in their child’s care. ADHD, attention-deficit/hyperactivity disorder.
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of the QPL content, but also that the intended users of
the document can actually be observed when locating
and understanding the information they need. The
mixed-methods approach afforded by user-testing also
allows for greater insight into how the document per-
forms by providing opportunities for qualitative feed-
back regarding its formatting, layout and usability.
User-testing has been traditionally applied to evaluate
the performance of written medicine information leaf-
lets and booklets, and also to other forms of patient
information.41–44 In the latter, more than 1 round of
revisions to the document and subsequent testing were
needed to reach the targets set by the EU for testing.
Perhaps the key difference between these and the
present study is that the ﬁrst version of the QPL was
designed by the research team using best practice princi-
ples of information design in the ﬁrst instance, whereas
previous studies have involved the testing of already pub-
lished medicine information leaﬂets and booklets that
may not have necessarily adhered to these guidelines.
This reinforces the potential beneﬁts associated with the
revision of any drafted patient information in line with
these guidelines, prior to testing. Only minimal changes
were made to the layout, structure and formatting of the
QPL as a result of the testing, further reinforcing
the importance of these principles and guidelines for
the production of written healthcare materials for consu-
mers. It is also important to note that the actual content
of the QPL, particularly the included questions,
remained largely unaltered throughout the user-testing
process. This is a testament to the rigorous process used
in the generation of the questions and their validation
by parents, consumer advocates, clinicians and research-
ers in our Delphi study (submitted for publication).
The success of the user-testing process was demon-
strated by the improvement in the ability of parents to
locate and understand key information points following
revisions to the original booklet. Perhaps most import-
antly, however, were the positive responses to the
concept of the QPL as a resource, particularly that it
would give parents conﬁdence to play an active role
during their child’s clinical consultations. This positive
response asserts the importance of previous work con-
ducted by the research team in elucidating the informa-
tion needs of parents of children with ADHD and
reinforces the appropriateness of the QPL as a resource
to assist them in meeting these needs.17
To the best of our knowledge, this is the ﬁrst
ADHD-speciﬁc QPL to be developed and the ﬁrst inter-
vention targeting communication between parents of
children with ADHD and their child’s clinicians with the
potential to enhance their capacity for SDM. This is par-
ticularly important in light of the ongoing controversies
surrounding ADHD and parents’ consequent desire for
clear and tailored information to assist with their treat-
ment decision-making. Furthermore, given the recent
interest in the development of programmes and inter-
ventions to afford patients greater opportunities for
active involvement in treatment decisions, we believe this
QPL is a well-timed and well-placed resource. This is
especially relevant for ADHD, an area where parents as
well as clinicians have been shown to view SDM favour-
ably but, seemingly, no work has yet been conducted to
assist in the realisation of this outcome.34 Therefore, the
development and ultimate use of this ADHD-speciﬁc
Box 1 Revisions made to the question prompt list (QPL)
content after round 1 of testing.
A. The main purpose of the booklet (Question 1).
▸ We modified the heading “Why should I use this booklet?”
to “How will this booklet help me?”
B. Using the booklet to prepare for an upcoming appointment
(Question 3).
▸ The section, “Using this booklet with your child’s doctor”
was divided with the following subheadings to help
navigation:
1. “Before your appointment”
2. “During your appointment”
3. “After your appointment”
C. Selecting which questions to ask the clinician (Question 6).
▸ We modified the heading, “How should I use this booklet?”
to “Which questions should I ask?”
Other content changes
▸ The font used for the subheadings in the treatment and future
expectations topics was made bold to help distinguish the
separate sections.
▸ The booklet was made more personal by including a section
at the beginning titled “This booklet belongs to…” where
parents could write their name alongside their child’s and
include a contact number in case of loss of the booklet.
▸ An additional section titled ‘My Contacts’ was added to the
back of the booklet to allow parents to write down the contact
details of their child’s school and the various healthcare pro-
fessionals involved in their child’s care.
▸ The addition of a question regarding the impact of diet on
attention-deficit/hyperactivity disorder (ADHD) as per the partici-
pants’ requests. The question was “How does diet affect ADHD?”
and was included under Topic 2, ‘Understanding ADHD’.
Box 2 Aesthetic revisions made to the question prompt
list (QPL) after round 1 of testing.
1. Section dividers
▸ Overhanging tabbed section dividers were created for each
of the QPL topics, also serving as a cover page for each
topic.
▸ The dividers were coloured in keeping with the colour-
coding used in the initial booklet.
2. Greater writing space
▸ Two double-sided additional lined pages were provided at
the end of each topic for the inclusion of further questions
or notes by parents.
3. Weight and finish of paper
▸ Heavier weight paper was used for the cover of the
booklet to enhance its durability.
▸ Matte-based paper was used for the content pages of the
booklet to allow for the use of different pens.
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QPL in clinical environments may prove to be one of
the ﬁrst steps taken towards speciﬁcally addressing this
void in the literature. As the QPL is anticipated to
improve parents’ understanding about ADHD and its
treatments, it may also serve to improve adherence to
medications or other treatments agreed on with
clinicians.
The ﬁndings of this study should be considered in
light of some limitations. We did not speciﬁcally enquire
about or record the treatment histories of the partici-
pants’ children nor did we assess their level of
ADHD-related knowledge or directly assess their health
literacy levels, although the parents’ level of educational
attainment was used as an indicator of their literacy. It is
possible that parents’ familiarity with certain treatments
and their ADHD-knowledge more generally may have
inﬂuenced their ability to locate and understand certain
pieces of information or questions. Furthermore, we
chose to recruit parents or carers of children with a clin-
ical diagnosis of ADHD to participate in this study,
rather than parents without any experience related to
the disorder. This decision was made to ensure that the
booklet was being evaluated by parents with a lived
experience related to ADHD and, in this way, that appro-
priate feedback could be obtained about the QPL.
User-testing speciﬁcally looks at whether people can
ﬁnd and understand information within a document,
and although it has beneﬁts including its mixed-
methods nature and small participant burden, it is
limited by its outcomes. The method does not test the
documents’ inﬂuence on treatment decision-making or
long-term outcomes such as adherence to therapy,
which require assessment in future work. It is important
that the usability, acceptability and impact of this QPL
are evaluated during clinical consultations between
parents and their child’s clinicians. We are currently
evaluating the use of the QPL in such settings. Pending
the outcomes of this study, we anticipate that there may
be potential for broader roll-out of the resource and its
integration as part of routine clinical care for these fam-
ilies. While we expect the QPL to be of beneﬁt to fam-
ilies regardless of what stage they are at with their child’s
ADHD, it is likely that it will be of particular use to
those families who are seeking medical advice regarding
a potential ADHD diagnosis. To ensure that these fam-
ilies are able to access the QPL as early as possible,
copies of the resource will be distributed to primary care
physicians (eg, general practitioners) for provision to
families being referred to specialists (eg, developmental
paediatricians). Copies will also be distributed to specia-
lists’ clinics to facilitate access to the resource for fam-
ilies who have already received an ADHD diagnosis. The
timing of QPL provision in these clinics would ultimately
be at the clinicians’ discretion but may be useful in situa-
tions where families are likely to have new concerns and
issues to discuss, for example, before starting a trial of
pharmacotherapy or as the child is approaching adoles-
cence. To increase the practicality for roll-out, the QPL
will also be uploaded to the Internet in a printer-friendly
format that can be downloaded by interested parents
and clinicians.
Conclusions
Guidelines for producing written healthcare materials
were used to inform the design of an ADHD-speciﬁc
QPL booklet intended for use by parents of children
with ADHD. This, coupled with the novel application of
user-testing methods to determine the performance of
the QPL, ultimately resulted in the development of a
highly relevant, easy to understand and user-friendly
resource. User-testing may provide a more structured
and rigorous approach to testing the performance of
future QPLs or written healthcare materials other than
written medicine information. The QPL itself is the ﬁrst
intervention targeted at addressing parents’ unmet
information needs about ADHD and its treatments. This
resource has the potential to empower parents’ treat-
ment decisions and to enhance the potential for SDM
during clinical consultations.
Contributors All authors contributed to the study design. RA conducted all
user-testing interviews and, with the assistance of PA, analysed the data. RA
wrote the manuscript, which was critically reviewed by DKR, KJM and PA.
Funding This research received no specific grant from any funding agency in
the public, commercial or not-for-profit sectors.
Competing interests DKR is the co-founder and academic advisor for Luto
Research Ltd, a company that provides performance-based health information
testing services.
Ethics approval The Human Research Ethics Committee at The University of
Sydney.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.
Open Access This is an Open Access article distributed in accordance with
the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license,
which permits others to distribute, remix, adapt, build upon this work non-
commercially, and license their derivative works on different terms, provided
the original work is properly cited and the use is non-commercial. See: http://
creativecommons.org/licenses/by-nc/4.0/
REFERENCES
1. Warikoo N, Faraone SV. Background, clinical features and treatment
of attention deficit hyperactivity disorder in children. Expert Opin
Pharmacother 2013;14:1885–906.
2. Arnsten AF. Fundamentals of attention-deficit/hyperactivity disorder:
circuits and pathways. J Clin Psychiatry 2006;67(Suppl 8):7–12.
3. Biederman J, Spencer T. Attention-deficit/hyperactivity disorder
(ADHD) as a noradrenergic disorder. Biol Psychiatry 1999;46:1234–42.
4. Wilens TE, Biederman J, Spencer TJ. Attention deficit/hyperactivity
disorder across the lifespan. Annu Rev Med 2002;53:113–31.
5. Wilens TE. Effects of methylphenidate on the catecholaminergic
system in attention-deficit/hyperactivity disorder. J Clin
Psychopharmacol 2008;28:S46–53.
6. del Campo N, Chamberlain SR, Sahakian BJ, et al. The roles of
dopamine and noradrenaline in the pathophysiology and treatment of
attention-deficit/hyperactivity disorder. Biol Psychiatry 2011;69:e145–57.
7. Pescosolido BA, Jensen PS, Martin JK, et al. Public knowledge and
assessment of child mental health problems: findings from the
national stigma study-children. J Am Acad Child Adolesc Psychiatry
2008;47:339–49.
8. Mayes R, Bagwell C, Erkulwater J. ADHD and the rise in stimulant
use among children. Harv Rev Psychiatry 2008;16:151–66.
9. Radomsky M. Kids on speed? [television broadcast]. Sydney:
Australian Broadcasting Corporation, 2014.
10 Ahmed R, et al. BMJ Open 2014;4:e006585. doi:10.1136/bmjopen-2014-006585
Open Access
10. Boyle CA, Boulet S, Schieve LA, et al. Trends in the prevalence of
developmental disabilities in US children, 1997–2008. Pediatrics
2011;127:1034–42.
11. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to
stop harming the healthy. BMJ 2012;344:e3502.
12. Frances A. The first draft of DSM-V. BMJ 2010;340:c1168.
13. Ghanizadeh A. Agreement between Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition, and the proposed
DSM-V attention deficit hyperactivity disorder diagnostic criteria: an
exploratory study. Compr Psychiatry 2013;54:7–10.
14. Batstra L, Frances A. DSM-5 further inflates attention deficit
hyperactivity disorder. J Nerv Ment Dis 2012;200:486–8.
15. Brinkman WB, Sherman SN, Zmitrovich AR, et al. Parental angst
making and revisiting decisions about treatment of attention-deficit/
hyperactivity disorder. Pediatrics 2009;124:580–9.
16. Hansen DL, Hansen EH. Caught in a balancing act: Parents’
dilemmas regarding their ADHD child’s treatment with stimulant
medication. Qual Health Res 2006;16:1267–85.
17. Ahmed R, Borst JM, Yong CW, et al. Do parents of children with
attention-deficit/hyperactivity disorder (ADHD) receive adequate
information about the disorder and its treatments? A qualitative
investigation. Patient Prefer Adherence 2014;8:661–70.
18. Ahmed R, Aslani P. Attention-deficit/hyperactivity disorder: an
update on medication adherence and persistence in children,
adolescents and adults. Expert Rev Pharmacoecon Outcomes Res
2013;13:791–815.
19. Narayan S, Hay J. Cost effectiveness of methylphenidate versus
AMP/DEX mixed salts for the first-line treatment of ADHD. Expert
Rev Pharmacoecon Outcomes Res 2004;4:625–34.
20. Chacko A, Newcorn JH, Feirsen N, et al. Improving medication
adherence in chronic pediatric health conditions: a focus on ADHD
in youth. Curr Pharm Des 2010;16:2416–23.
21. Clay D, Farris K, McCarthy AM, et al. Family perceptions of
medication administration at school: errors, risk factors, and
consequences. J Sch Nurs 2008;24:95–102.
22. Ahmed R, Borst J, Wei YC, et al. Parents’ perspectives about factors
influencing adherence to pharmacotherapy for ADHD. J Atten Disord
2013. doi:10.1177/1087054713499231.
23. Ahmed R, McCaffery KJ, Aslani P. Factors influencing parental
decision making about stimulant treatment for attention-deficit/
hyperactivity disorder. J Child Adolesc Psychopharmacol
2013;23:163–78.
24. Sciberras E, Iyer S, Efron D, et al. Information needs of parents of
children with attention-deficit/hyperactivity disorder. Clin Pediatr
2010;49:150–7.
25. Hummelinck A, Pollock K. Parents’ information needs about the
treatment of their chronically ill child: a qualitative study. Patient
Educ Couns 2006;62:228–34.
26. Coulter A, Entwistle V, Gilbert D. Sharing decisions with patients: is
the information good enough? BMJ 1999;318:318–22.
27. Charles C, Gafni A, Whelan T. Decision-making in the physician–
patient encounter: revisiting the shared treatment decision-making
model. Soc Sci Med 1999;49:651–61.
28. Joosten EAG, DeFuentes-Merillas L, de Weert GH, et al. Systematic
review of the effects of shared decision-making on patient
satisfaction, treatment adherence and health status. Psychother
Psychosom 2008;77:219–26.
29. Charles C, Gafni A, Whelan T. Shared decision-making in the
medical encounter: what does it mean? (or it takes at least two to
tango). Soc Sci Med 1997;44:681–92.
30. Drotar DC, Crawford P, Bonner M. Collaborative decision-making
and promoting treatment adherence in pediatric chronic illness.
Patient Intell 2010;2:1–7.
31. Wolraich M, Brown L, Brown RT, et al. ADHD: clinical practice
guideline for the diagnosis, evaluation, and treatment of
attention-deficit/hyperactivity disorder in children and adolescents.
Pediatrics 2011;128:1007–22.
32. (CADDRA) CADHDRA. Canadian ADHD practice guidelines. 3rd
edn. Toronto: CADDRA, 2011.
33. National Health and Medical Research Council. Clinical practice
points on the diagnosis, assessment and management of attention
deficit hyperactivity disorder in children and adolescents. Canberra,
Australia: Australian Government, 2012.
34. Fiks AG, Hughes CC, Gafen A, et al. Contrasting parents’ and
pediatricians’ perspectives on shared decision-making in ADHD.
Pediatrics 2011;127:e188–96.
35. Clayton JM, Butow PN, Tattersall MH, et al. Randomized controlled
trial of a prompt list to help advanced cancer patients and their
caregivers to ask questions about prognosis and end-of-life care.
J Clin Oncol 2007;25:715–23.
36. Clayton J, Butow P, Tattersall M, et al. Asking questions can help:
development and preliminary evaluation of a question prompt list for
palliative care patients. Br J Cancer 2003;89:2069–77.
37. Langbecker D, Janda M, Yates P. Development and piloting of a
brain tumour-specific question prompt list. Eur J Cancer Care
2012;21:517–26.
38. Centers for Disease Control and Prevention. Simply put: a guide for
creating easy-to-understand materials. Atlanta, Georgia: Centers for
Disease Control and Prevention, 2009.
39. Jay E, Aslani P, Raynor D. User testing of consumer medicine
information in Australia. Health Educ J 2011;70:420–7.
doi:10.1177/0017896910376131
40. Sless D, Shrensky R. Writing about medicines for people: usability
guidelines for consumer product information: Australian
Self-Medication Industry, Incorporated. 2007.
41. Knapp P, Raynor DK, Silcock J, et al. Performance-based readability
testing of participant materials for a phase I trial: TGN1412. J Med
Ethics 2009;35:573–8.
42. Knapp P, Raynor DK, Silcock J, et al. Can user testing of a clinical
trial patient information sheet make it fit-for-purpose? A randomized
controlled trial. BMC Med 2011;9:89.
43. Knapp P, Raynor DK, Silcock J, et al. Performance-based readability
testing of participant information for a Phase 3 IVF trial. Trials
2009;10:79.
44. Knapp P, Wanklyn P, Raynor DK, et al. Developing and testing a
patient information booklet for thrombolysis used in acute stroke. Int
J Pharm Pract 2010;18:362–9.
45. Harris E, Enright D. New words for cautionary and advisory labels
make them easily understood. Pharm J 2011;286:278–9.
46. Dale E, Chall JS. A formula for predicting readability. Educ Res Bull
1948;27:11–28.
47. Laughlin GHM. SMOG grading—a new readability formula. J Read
1969;12:639–46.
48. Raynor DK. User testing in developing patient medication
information in Europe. Res Social Adm Pharm 2013;9:640–5.
49. Raynor DK, Knapp P, Silcock J, et al. “User-testing” as a method for
testing the fitness-for-purpose of written medicine information.
Patient Educ Couns 2011;83:404–10.
50. Kelly M. The role of theory in qualitative health research. Fam Pract
2010;27:285–90.
Ahmed R, et al. BMJ Open 2014;4:e006585. doi:10.1136/bmjopen-2014-006585 11
Open Access
